← Back to all trials
Completed
NCT05710354
The Study of High-protein Nutritional Support Impact on Postoperative Outcomes in Patients With Primary Lung Cancer
Conditions: Lung Cancer
Sex: All
Ages: 18 Years – 69 Years
Enrollment: 114
Sponsor: Enrollme.ru, LLC
Location: Russian Federation
Summary
The study was aimed to evaluate the impact of perioperative nutritional support with high-protein mixtures on the risk of postoperative complications, postoperative recovery of respiratory functions in patients with lung cancer, nutritional status and quality of life of patients.
Possible adverse events were also studied and described.
Eligibility Criteria
Inclusion Criteria:Presence of morphological verification of non-small cell lung cancer (NSCLC) without distant metastases;Appointment of surgical treatment for primary lung cancer with anatomical resection of the lung (lobectomy, bilobectomy or pneumonectomy);Nutritional deficiency or risk of its development (≥3 points on the Nutrition Risk Screening 2002 (NRS-2002) scale);No history of nutritional support;ECOG (Eastern Cooperative Oncology Group Performance Status Scale) score 0 - 2;Life expectancy over 3 months;Absence of serious diseases of the gastrointestinal tract, disorders of the liver, kidneys, systemic blood diseases and metabolic disorders at the time of inclusion in the study;Absence of severe uncontrolled concomitant chronic diseases and acute diseases (including infectious ones);Availability of signed informed consent for inclusion in the study and processing of personal dataExclusion Criteria:Terminal state of the patient, ECOG (Eastern Cooperative Oncology Group Performance Status Scale) 3-4;State of refractory cachexia;Bleeding, serious injury or blood transfusions in the previous 6 months;Decay / abscess in the area of the tumor lesion;Presence at the same time of a tumor process of another localization, metastatic lesion of the lungs;The presence of concomitant diseases in the stage of decompensation;Pregnancy or lactation;Allergy to or intolerance to any of the components of Nutridrink Compact Protein, galactosemia, allergy to cow's milk proteins;The presence of contraindications to the use of enteral nutritionParticipation in another study currently or in the past 30 days;Any other medical or non-medical reason that, in the physician's opinion, may prevent the patient from participating in the study
Source: ClinicalTrials.gov (NCT05710354). StuddyBuddy aggregates publicly available trial information.
